NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
2.557
-0.543 (-17.52%)
Dec 3, 2024, 12:20 PM EST - Market open
NLS Pharmaceutics AG Employees
As of December 31, 2021, NLS Pharmaceutics AG had 7 total employees, including 6 full-time and 1 part-time employees.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$942,161
Market Cap
4.85M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ainos | 46 |
| Sintx Technologies | 43 |
| Viracta Therapeutics | 40 |
| Aethlon Medical | 14 |
| GRI Bio | 4 |
| Quoin Pharmaceuticals | 4 |
| GT Biopharma | 2 |
| Cyclerion Therapeutics | 1 |
NLSP News
- 15 days ago - NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders - Accesswire
- 4 weeks ago - NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement - Accesswire
- 5 weeks ago - NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements - Accesswire
- 6 weeks ago - NLS Pharmaceutics Secures Key Patent in Japan for Mazindol ER in the Treatment of Heroin Dependence - Accesswire
- 7 weeks ago - NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules - Accesswire
- 2 months ago - NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split - Accesswire
- 4 months ago - Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump - Benzinga
- 4 months ago - NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge - Accesswire